BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 21.55
-0.25 (-1.15%)
Mar 23, 2026, 12:09 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 1.43 billion as of March 23, 2026. Its market cap has decreased by -12.80% in one year.
Market Cap
1.43B
Enterprise Value
850.31M
Revenue
226.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.55
Market Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 1.43B, an increase of 19.07%. That is a compound annual growth rate of 0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.43B | -25.85% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 2.79B |
| Vicore Pharma Holding AB | 2.67B |
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 2.02B |
| Diamyd Medical AB | 1.75B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Genovis AB (publ.) | 1.07B |